David Abrams acquired 1.27M Nuvation Bio shares worth $6.53M. That's 0.12% of their equity portfolio (11th largest holding). David Abrams started to build up the position in Nuvation Bio in Q1 2021. Since then they sold 2.54M shares. The investor's estimated purchase price is $14.6M, resulting in a loss of 55%.